Ncardia Services B.V.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ncardia Services B.V. - overview
Established
2010
Location
-, -, Netherlands
Primary Industry
Biotechnology
About
Founded in 2010 by Shinya Yamanaka and Kazutoshi Takahashi, and based in Leiden, Netherlands, Ncardia Services B. V. was formed following the merger of Pluriomics B. V.
and Axiogenesis AG. The firm operates as a stem cell drug discovery and development company. In November 2021, Ncardia Services B. V.
raised USD 60 million in venture funding led by investor Kiniciti. The company collaborates with biopharmaceutical businesses to develop new treatments for a variety of modalities at any stage of development by utilizing the power of stem cell technologies in drug discovery and cell therapy. The business's focus is on the creation and production of human induced pluripotent stem cell (hiPSC)-derived goods and services for drug discovery, safety pharmacology, and disease modeling.
Current Investors
Société Régionale d'Investissement de Wallonie, Vesalius Biocapital, High-Tech Gruenderfonds
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.ncardia.com
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Ncardia Services B.V. - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | (514,049) | 92,474 | (412,452) | (1,263,088) | (1,628,345) | - | - | - | - | - |
| Operating Income (USD) | (555,456) | 25,379 | (488,586) | (1,365,565) | (1,688,470) | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (518,207) | 97,150 | (328,332) | (21,353,255) | (3,102,506) | - | - | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - |
Ncardia Services B.V. - employee data
Ncardia Services B.V. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman of the Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.